← Leaderboards
Alan Fowler
Georgetown University
$61,936
Attributed
$61,936
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $32.8K · FY2020–21$50K$37.5K$25K$12.5K$0
'20
'21
Funding mix
By agency
NIH$61,936 · 1
By mechanism
F31$61,936 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Habtom W Ressom$10,889,463
- Charbel Moussa$7,027,361
- James N Baraniuk$4,870,559
- Sonia De Assis$3,222,376
- Kristen Kathleen Foster$1,008,214
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAge-YearsClinical TrialsAffectAmyloid Beta-ProteinAnimal ModelAttenuatedAutophagocytosisBiologicalBiological MarkersBlood - Brain Barrier AnatomyBrainCerebrospinal FluidCerebrospinal Fluid ProteinsAlpha SynucleinCognitionCohortComputer Software3,4-Dihydroxyphenylacetic AcidData MiningDifferential ExpressionDiscoidin ReceptorDisease ProgressionDisinhibition
Grant awards (2)
Utilizing microRNA in cerebrospinal fluid to evaluate the effects of tyrosine kinase inhibition via Nilotinib on gene regulation in individuals with Parkinson's disease or Alzheimer's disease$29,116
F31 · FY2021 · NS · contact PI
Utilizing microRNA in cerebrospinal fluid to evaluate the effects of tyrosine kinase inhibition via Nilotinib on gene regulation in individuals with Parkinson's disease or Alzheimer's disease$32,820
F31 · FY2020 · NS · contact PI